Hemostasis and Tissue Sealing Agents Market to Experience Significant Growth Due to Aggressive Marketing Strategies

On account of numerous manufacturers competing with each other for greater profits, the global market for hemostasis and tissue sealing agents has been dubbed as fragmented. Most of the top-notch players in the market are concentrated in Europe and North America. Some such players are Johnson & Johnson Services, Inc., Ethicon, Inc., Baxter, CryoLife, Inc., Pfizer, Inc., and C.R. Bard, Inc. (Davol, Inc.). 

Among them, Johnson & Johnson led the market in 2013 with a 21.5% share in the global revenue by dint of a wide array of product offerings, massive geographical outreach, and astute marketing strategies. Pfizer, Inc. came in second on account of mergers and acquisitions, which helped ramp up its market share. Besides that, the company’s product offerings boosted its growth in the global hemostasis and tissue sealing agents market.

On account of the highly competitive nature of the global hemostasis and tissue sealing agents market, the bargaining power of buyers, which include mainly clinics, hospitals, and other healthcare facilities, is high. Most of the dominant companies compete with each other on the basis of price, thereby driving them down. Expanding at a healthy pace, the global hemostasis and tissue sealing agents market is expected to reach a value of US$5.235 bn by 2020.

You can purchase and download the full report
http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4018

Rising Disposable Income makes Asia Pacific Most Attractive Market

Product-wise, the global hemostasis and tissue sealing agents market can be segmented broadly into two categories – topical hemostats and adhesive and tissue sealing agents. Of the two, topical hemostats held a dominant market share in 2015 vis-à-vis revenue, which stood at at US$2.05 bn. In the coming years too, it is expected to hold on to its leading position. This is mainly because topical hemostats steal a march over similar wound closure medical devices through more effective control of bleeding, especially during surgical procedures. Further, they bring down chances of post-operative complications and cost less. The market for adhesive tissue sealing agents, which act as a protective barrier to prevent leakage of fluid from the surgical site, is predicted to grow at a healthy pace too.

Geographically, North America has dominated the market for so long with maximum share. It is expected to maintain its position in the coming years and increase its share marginally to 36.3% in 2020. Europe follows next and Asia Pacific holds the third position. As far as market attractiveness is concerned, TMR predicts that Asia Pacific is likely to emerge as the frontrunner in the near future on account of reduced operating cost in the region, liberal regulatory environment, and rising disposable income of the people. This is already drawing investments from big ticket companies in the region.

Innovation in Product Offerings a Key Growth Driver

The growth in the global hemostatis and tissue sealing agents market has been brought about in part by the growing preference for minimally-invasive surgical procedures and a burgeoning elderly population that requires surgeries more than people of any other age group. The biggest thrust to the market, however, has been provided by the introduction and fast approval of novel hemostat and sealant products. “The introduction of fibrin sealant products, for example, has expanded the application areas in drug delivery mechanism and adhesion prevention,” informs the lead analyst of the TMR report.

Countering the market growth of hemostat and tissue sealant products are steep expenditure involved in developing the products and strict regulatory approvals. “Ethical concerns regarding the use of animal-derived components such as gelatin and collagen and human-derived components such as albumin and fibrin also restrict the uptake of these products,” points out the analyst.

Browse Research Report on Global Hemostasis and Tissue Sealing Agents Market:
http://www.transparencymarketresearch.com/hemostasis-tissue-sealing-agents-market.html

North America HbA1c Testing Devices Market Revenue and Industry Share 2019

Some of the prominent players identified in the global market for hemoglobin A1c testing devices, based on the number of products, include Bio-Rad Laboratories, Inc., Tosoh Corporation, Siemens Healthcare, F. Hoffmann-La Roche Ltd, Alere, Inc., Chek Diagnostics, Danaher Corporation, and Trinity Biotech plc. These prominent players dominate the market for hemoglobin A1c testing devices with their exclusive products. 

For example, Bio-Rad Laboratories, Inc., offers devices based on ion-exchange HPLC and boronate affinity chromatography. Its ‘in2in’ point-of-care device is the latest addition with the automated boronate affinity chromatography technique. Additionally, Tososh Corporation offers many HbA1c testing devices based on ion-exchange HPLC technology whereas Siemens Healthcare presents two leading HbA1c testing products with immunoassay technology. According to a report by Transparency Market Research, the global hemoglobin A1c testing market is expected to reach US$1.8 bn by 2019.

Request For Discount On This Research Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1620

POC HbA1c Testing Devices Market Projected for Robust Growth

The global hemoglobin A1c testing devices market is segmented on the basis of end use and technology. Based on end use, this study includes laboratory and point-of-care (POC) testing devices. Laboratory testing devices continue to be the leading segment in the global market by end use and is projected to reach a valuation of US$1.1 bn by 2019. The POC HbA1c testing devices market, on the other hand, is expected to grow at a higher CAGR during the forecast period owing to the rising demand for these devices in developing economies such as India, Brazil, Africa, and others where access to laboratory testing is limited.

Geographically, North America holds the dominant share in the global market for hemoglobin A1c testing devices, owing to high patient awareness levels about HbA1c testing. This market share is, however, is expected to decline by 2019 with Asia Pacific gaining much traction by the end of the forecast period. The report notes that the market in the emerging economies of the Middle East, Africa, and Latin America is driven by factors such as the presence of high unmet healthcare needs, the high prevalence of diabetes, and increasing awareness about the various HbA1c testing technologies.

Exponentially Rising Cases of Diabetics Driving Demand

As per the International Diabetes Federation (IDF), the number of diabetics in the world is projected to reach 642 million by 2040, rising from 415 million in 2015. The report identifies this significant chunk of population as the primary driver in the market for hemoglobin A1c testing devices. Western Pacific and Southeast Asia are projected to have the most number of diabetics by 2035. Moreover, rising geriatric population is another factor that is driving the demand for hemoglobin A1c testing devices. People aged over 55 commonly suffer from diabetes and other endocrine diseases. Furthermore, the diabetes control and complications trial (DCCT) and United Kingdom prospective diabetes study (UKPDS) researches have established the fact that hemoglobin A1c testing on a regular basis improves the health outcome of a diabetes patient. This proven benefit is expected to encourage the market for the same during the forecast period. Conversely, the presence of viable and cost-efficient conventional blood glucose testing is hindering the awareness and concurrent adoption of hemoglobin A1c testing devices, globally.

According to the author of the report, “Emerging economies such as India, China, Philippines, Brazil, and other high growth countries in Asia Pacific, Africa, and the Middle East offer several untapped opportunities. These countries are investing heavily on improving their healthcare infrastructure. Also, the rapid commercialization of devices for diagnosis of diabetes is further fueling the market.”

Browse Research Report on Global Hemoglobin A1c Testing Devices Market:
http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html

Global Hospital Microbiology Testing Market: Rising Need to Manage Infectious Disease to Boost Demand

The global hospital microbiology testing market is estimated to witness significant growth in the coming years due to a rise in the awareness level among patients regarding respiratory infections, inflammatory disorders, or any such chronic problems. The hospital microbiology testing market is studied in a new report by Transparency Market Research (TMR). The report is titled, ‘Hospital Microbiology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.’ Reimbursement policies and favorable economic conditions are expected to drive the market in the forecast period.

Download Complete Healthcare Analytical Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4065

The report studies the global hospital microbiology testing market’s historical performance and presents detailed forecasts regarding the market’s development between 2016 and 2024. The competitive landscape, regional segmentation, and key drivers and restraints of the global hospital microbiology testing market are elaborated upon in the report. The study also discusses key trends and opportunities in the market and bases its forecasts on these important factors.

The growing prevalence of infectious diseases, outbreaks of epidemics, and most importantly, growing healthcare expenditure have resulted in a significant growth of the hospital microbiology testing market worldwide. Technological advancements, increasing funding, public-private investments in the field of life science researches, and research grants have resulted in higher efficiency, fueling the adoption of microbiology testing in hospitals. In addition to this, a rise in the awareness among people in developing nations regarding sex-related health issues is also expected to drive the hospital microbiology testing market. 

The growing incidence of severe and fatal diseases such as HIV, human papilloma virus (HPV), and Hepatitis B and C is increasing the demand for hospital microbiology testing. Improved hospital infrastructures and adequate management of threats of infectious diseases will also aid the market’s growth in the coming years. Additionally, hospital microbiology testing enables effective communication between the doctor and microbiology laboratory. 

The report segments the global hospital microbiology testing market on the basis of geography, disease type, and diagnostic technologies. By diagnostic technology, the market is segmented into differential light scattering, molecular diagnostics, immunoassays, monoclonal antibodies, liposome, flow cytometry, gel micro-droplets, and chromatography. On the basis of disease type, the market is segmented into encephalitis, trichomonas vaginalis, antrax, babesiosis, E. coli, brucella, ebola virus, aids, west nile virus, streptococci, tuberculosis, staphylococcus aureus, gonorrhea, toxoplasmosis, chancroid, chagas disease, syphilis, cyclospora cayetanensis, creutzfeldt-jakob's disease, echovirus, epstein-barr virus, enteroviruses, cytomegalovirus, giardia lamblia, candida, adenovirus, campylobacter, chlamydia, clostridium difficile, blastocystis hominis, coxsackieviruses, and coronaviruses.

Key players profiled in the report include Abbott Diagnostics, bioMerieux, Affymetrix, Ortho-Clinical Diagnostics, Cepheid, Hologic, Roche Diagnostics, Qiagen, Thermo Fischer Scientific, and Siemens. 

Browse Research Report on Global Hospital Microbiology Testing Market:
http://www.transparencymarketresearch.com/hospital-microbiology-testing-market.html

Intravenous (IV) Access Devices Market: Growth in Asia Pacific due to Large Geriatric and Patient Pool

The global intravenous (IV) access devices market is highly fragmented, wherein a few top players, namely Hospira, Inc., CareFusion Corporation Becton, Dickinson and Company, and Baxter International, commanded over half the total market revenue in 2012. Hospira, Inc. dominated the market at 17.4% in 2012 and was followed by Becton, Dickinson and Company, CareFusion Corporation, and Baxter International.

Competition among the dominant and other players in the market for intravenous access devices is high. On account of this, as well as limited product differentiation, there has been a continuous price war in the market. One of the popular business strategies leveraged by the manufacturers of intravenous access devices to retain their clients is to sign contracts with end users such as hospitals and diagnostic centers path labs to provide long-term warranty and post-purchase services.

Innovative products of various well-entrenched players such as pen needles, SmartSite, Trellis Peripheral Infusion Pumps, and Echelon catheters have helped them further improve their sales and revenues.

Barriers to entry are low in the global market for intravenous access devices. This, coupled with stiff competition, will result in the healthy growth of the market, which is expected to be worth US$46.4 bn by 2019. 

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1723

Asia Pacific Increasingly Attractive Market due to Large Geriatric Population and Patient Pool

Product-wise, intravenous access devices can be divided into intravenous needles, intravenous infusion pumps, and intravenous catheters. Intravenous catheters come in two different forms – central catheters and midline peripheral catheters. Central catheters are further segmented into peripherally inserted central catheters (PICC) and centrally inserted central catheters. TMR reveals that intravenous catheters contributed the most toward the global market. In terms of percentage share contribution, the segment has accounted for almost half the market and is slated to increase marginally in the forthcoming years. Its market was valued at US$17.11 bn in 2015. It was followed by intravenous needles in terms of market share.

From a geographical standpoint, North America has accounted for the maximum market share with a revenue of US$15.72 bn in 2015. The drastic increase in cancer patient population has resulted in the growth of the market. Europe follows next, with Germany, the U.K., Italy, France, and Spain being major markets. Asia Pacific, however, is the most lucrative market and is predicted to demonstrate the strongest growth through 2019 because of a large geriatric population and patient pool. The market is powered mostly by China, followed by other regions, namely Japan, Koreas, the Indian subcontinent, Southeast Asia, Australia, and New Zealand.

Growing Number of Elderly Worldwide Driving Market Growth

Intravenous access devices find application in administration of various medications such as analgesics, antipyretics, anesthesia, and anticancer drugs. The growing occurrence of cancer, tuberculosis (TB), and viral infections is expected to drive the market. Yet another factor that is likely to boost growth is an increasing geriatric population worldwide.

“Due to an improvement in healthcare policies in various nations such as the U.S., Japan, the U.K. and China, access to various diagnostic and treatment services has been enhanced, which has, in turn, increased the life expectancy of the population. Elderly people are prone to various chronic and acute diseases; hence an increase in the patient pool. These patients are usually unable to take oral medication and are therefore given medication and nutrition intravenously,” explains the analyst of the TMR report.

Countering market growth are concerns over risks associated with the use of needles. Also hampering the market is the lack of regulatory approval for intravenous insulin in infusion pumps in important markets such as the U.S., which is home to a large diabetic population.

Browse Research Report on Global Intravenous Access Devices Market:
http://www.transparencymarketresearch.com/intravenous-access-devices.html